Neurocrine Biosciences (NBIX) Income from Non-Controlling Interests (2011 - 2026)

Neurocrine Biosciences' Income from Non-Controlling Interests history runs 12 years deep, the most recent figure standing at -$12.7 million for Q1 2026.

• Quarterly Income from Non-Controlling Interests fell 847.06% year-over-year to -$12.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.9 million (down 327.08% YoY) and the FY2025 annual result came in at $3.5 million, up 3600.0% from the prior year.
• Income from Non-Controlling Interests was -$12.7 million for Q1 2026 at Neurocrine Biosciences, down from -$900000.0 in the prior quarter.
• Across five years, Income from Non-Controlling Interests topped out at $9.1 million in Q3 2024 and bottomed at -$12.7 million in Q1 2026.
• A 5-year average of -$368750.0 and a median of -$100000.0 in 2023 frame the typical range for Income from Non-Controlling Interests.
• Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests tumbled 866.67% — and 2024, when it jumped 1037.5%.
• Neurocrine Biosciences' Income from Non-Controlling Interests stood at $3.2 million in 2022, then soared by 118.75% to $7.0 million in 2023, then plunged by 172.86% to -$5.1 million in 2024, then jumped by 82.35% to -$900000.0 in 2025, then tumbled by 1311.11% to -$12.7 million in 2026.
• Business Quant data shows NBIX's Income from Non-Controlling Interests at -$12.7 million in Q1 2026, -$900000.0 in Q3 2025, and $2.7 million in Q2 2025.